BDBM276099 N-((1-(3-(Difluoromethyl)phenyl)-1H-1,2,3-triazol-4-::US10071988, Example 6::US10233173, Example 6

SMILES FC(F)c1cccc(c1)-n1cc(CNc2ncccn2)nn1

InChI Key InChIKey=KZUZBLIVDLIHPM-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 276099   

TargetGlutamate receptor ionotropic, NMDA 1/2B(Homo sapiens (Human))
Janssen Pharmaceutica

US Patent
LigandPNGBDBM276099(N-((1-(3-(Difluoromethyl)phenyl)-1H-1,2,3-triazol-...)
Affinity DataIC50:  1.06E+4nMAssay Description:NMDA receptors are ion channels that are highly permeable to Ca2+ ions, rendering it possible to monitor NMDA receptor function using cell-based calc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetRetinoic acid receptor RXR-alpha(Homo sapiens (Human))
Janssen Pharmaceutica

US Patent
LigandPNGBDBM276099(N-((1-(3-(Difluoromethyl)phenyl)-1H-1,2,3-triazol-...)
Affinity DataIC50:  1.06E+4nMpH: 7.4 T: 2°CAssay Description:NMDA receptors are ion channels that are highly permeable to Ca2+ ions, rendering it possible to monitor NMDA receptor function using cell-based calc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent